HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis (Q33941618)

30 July 2017

HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis (English)

1 reference

Major histocompatibility complex, class I, G

30 July 2017

1 reference

protection from natural killer cell mediated cytotoxicity

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

5

Dausset J

1 reference

30 July 2017

Riteau B

1

1 reference

30 July 2017

Rouas-Freiss N

2

1 reference

30 July 2017

Menier C

3

1 reference

30 July 2017

Paul P

4

1 reference

30 July 2017

Carosella ED

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

30 July 2017

Journal of Immunology

1 reference

30 July 2017

166

1 reference

30 July 2017

5018-5026

1 reference

30 July 2017

8

1 reference

The immunotolerance role of HLA-G.

30 July 2017

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

HLA-G polymorphisms and allele frequencies in Caucasians.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

Homozygous human TAP peptide transporter mutation in HLA class I deficiency

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

Implication of HLA-G molecule in heart-graft acceptance.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

Non-classic sHLA class I in human oocyte culture medium.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

Early human decidual cells exhibit NK activity against the K562 cell line but not against first trimester trophoblast

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

HLA-G1 protein expression is not essential for fetal survival

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

Co-dominant expression of the HLA-G gene and various forms of alternatively spliced HLA-G mRNA in human first trimester trophoblast.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

Homozygous HLA-G*0105N healthy individuals indicate that membrane-anchored HLA-G1 molecule is not necessary for survival

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

HLA-G inhibits the allogeneic proliferative response

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

A class I antigen, HLA-G, expressed in human trophoblasts

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

The role of peptide presentation in the physiological function of HLA-G.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

The class I-b molecule Qa-1 forms heterodimers with H-2Ld and a novel 50-kD glycoprotein encoded centromeric to I-E beta

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

Modulation of HLA-G antigens expression in myelomonocytic cells.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

The short forms of HLA-G are unlikely to play a role in pregnancy because they are not expressed at the cell surface

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

The full length HLA-G1 and no other alternative form of HLA-G is expressed at the cell surface of transfected cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

Biochemical characterization of CD1d expression in the absence of beta2-microglobulin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

HLA-G expression during preimplantation human embryo development

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

HLA-G: a tolerance molecule from the major histocompatibility complex

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.166.8.5018

Identifiers

DOI

10.4049/JIMMUNOL.166.8.5018

1 reference

30 July 2017

1 reference